ArticleBMC veterinary research2019
Identification and antimicrobial susceptibility profile of Escherichia coli isolated from backyard chicken in and around ambo, Central Ethiopia.
Article in BMC veterinary research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 59 citations in OpenAlex.
- PCR-based detection of Chicken Anemia Virus and Escherichia coli co-infection in commercial poultry flocks in Lahore, Punjab, Pakistan.Veterinary research communications · 2026Article
- Phenotypic and genomic analysis of antimicrobial resistantFrontiers in microbiology · 2026Article
- Antibiotic Resistance of Profiles ofVeterinary medicine international · 2026Article
- Antimicrobial resistance profiling of Salmonella and Escherichia coli isolates from conventional poultry farms in Hossana Town, Central Ethiopia.BMC veterinary research · 2025Article
- Molecular Epidemiology and Resistant Gene Mapping of Bacterial Isolates from Houbara bustards.Current microbiology · 2025Article
- Corrigendum to "Multidrug resistance from a one health perspective in Ethiopia: a systematic review and meta-analysis of literatures (2015-2020)" [One Health 14(2022) 1-12/100390].One health (Amsterdam, Netherlands) · 2025Article
- A Multidrug-ResistantVeterinary sciences · 2025Article
- Prevalence and antimicrobial resistance of Salmonella and pathogenic E. coli in broiler farms, Wakiso district, Uganda.PloS one · 2025Article
- Article
- Assessment of Knowledge, Attitude and Practice (KAP) Regarding Antimicrobial Usage and Resistance Among Animal Health Professionals of East Wallaga Zone, Oromiya, Ethiopia.Veterinary medicine (Auckland, N.Z.) · 2024Article
- Occurrence and antimicrobial susceptibility patterns of Escherichia coli and Escherichia coli O157 isolated from cow milk and milk products, Ethiopia.Scientific reports · 2023Article
- Antimicrobial resistance profiles ofJAC-antimicrobial resistance · 2023Article
- Prevalence of multidrug-resistant and extended-spectrum β-lactamase-producingVeterinary world · 2023Article
- Resistance and virulence gene analysis and molecular typing ofFrontiers in cellular and infection microbiology · 2023Article
- Livestock producers' knowledge, attitude, and behavior (KAB) regarding antimicrobial use in Ethiopia.Frontiers in veterinary science · 2023Article
- Occurrence of extended- spectrum β-lactamase harboringFrontiers in cellular and infection microbiology · 2023Article
- Development and Validation of a New TaqMan Real-Time PCR for the Detection ofMicroorganisms · 2022Article
- Evaluation of Sodium Alginate Stabilized Nanoparticles and Antibiotics against Drug ResistantOxidative medicine and cellular longevity · 2022Article
- Multidrug resistance, biofilm formation, and virulence genes ofVeterinary world · 2021Article
- Development and Validation of Two Diagnostic Real-Time PCR (TaqMan) Assays for the Detection ofMicroorganisms · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEscherichia coli is bacteria that exist as commensal in the intestine of animals and humans, but pathogenic strains cause disease in chickens. The development of antimicrobial resistance in E. coli is one of major concern worldwide. A cross-sectional study was conducted from November, 2015 to April, 2016 in and around Ambo town on backyard chicken with the objectives of isolating E. coli from selected visceral organs, assessment of potential risk factor and determination of antimicrobial resistance pattern of the isolates.
resultsThe overall isolation rate of E. coli was 11.5% (80/694) [95% CI: 9.64-14.61] and 32.5% (62/191) [95% CI: 25.39-39.09] at organ and chicken level, respectively. E. coli isolation rate was 15.2% (29/191), 13.6% (27/191), 6.3% (12/191) and 10.7% (13/121) from spleen, liver, kidney and ovary samples, respectively. The multivariable logistic regression analysis revealed higher probability of E. coli isolation from adult (adjusted Odds ratio [aOR] =2.5, P = 0.013) than younger chickens, from clinically sick chickens (aOR = 3.0, P = 0.003) than apparently healthy. E. coli isolates were 100% susceptible to ciprofloxacin, norfloxacin and sulfamethoxazole-trimethoprim followed by 89-63.4% susceptibility to gentamicin, streptomycin, ceftazidime, nalidxic acid, nitrofurantoin, kanamycin, amikacin and chloramphenicol. Whereas, 100% resistance was observed against cloxacilin, cefotaxime and amoxicillin, whereas 92.7 and 46.3% were resistant to cefuroxime, and tetracycline, respectively. Multidrug resistant (MDR) was observed in 78.1% (64/82) of the isolates which exhibited 5 different MDR patterns to 7 antimicrobial classes.
conclusionsHigher isolation rate of E. coli was observed from visceral organs of chickens. Age and health status were predictors of E. coli isolation. Remarkable numbers of the isolates are resistant to different antimicrobials and multidrug resistant E coli isolates are widespread in the area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.